AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17913961
Drug: TNF-alpha -308
RxNorm normalized name: alpha-Tocopherolquinone
DrugBank: Tocopherylquinone (DB14094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TNF-alpha -308 G/A genotype distributions in women without pregnancy complications (controls)
Trial: 17913961
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of TNF-alpha -308 G/A genotype distributions between cases and controls
Trial: 17913961
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of TNF-alpha -308 G/A allele frequencies between cases and controls
Trial: 15911462
Drug: Zinc as
RxNorm normalized name: Zinc aspartate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc as an adjuvant to malaria therapy
Trial: 12126383
Drug: Refrigerant spray
RxNorm normalized name: Refrigerant 114
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Refrigerant spray (RS)
Trial: 10726107
Drug: Postprandial lipemia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postprandial lipemia (200 ml of 30% cream) in IHD patients
Trial: 10726107
Drug: Postprandial lipemia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postprandial lipemia (200 ml of 30% cream) in healthy controls
Trial: 1786763
Drug: Accelerated hyperfractionation
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated hyperfractionation with twice-a-day irradiation (Group B)
Trial: 15592062
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg tamsulosin once daily every day
Trial: 15592062
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg tamsulosin once daily every other day
Trial: 12095019
Drug: Propofol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2.5 mg kg(‐1) plus fentanyl 1 microg kg(‐1))
Trial: 7600031
Drug: Etoposide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoposide (50 mg/m2/day) p.o. for 21 consecutive days and cisplatin (100 mg/m2) i.v. on day 1 every 28 days for up to six courses
Trial: 7600031
Drug: Etoposide and
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Etoposide and cisplatin combination therapy
Trial: 220889
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of naloxone
Trial: 220889
Drug: Endorphin injections
RxNorm normalized name: beta-endorphin human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endorphin injections
Trial: 16704584
Drug: Potassium permanganate
RxNorm normalized name: Potassium Permanganate
DrugBank: Potassium permanganate (DB13831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium permanganate 8 mg.l(‐1)
Trial: 15035935
Drug: Mandatory drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandatory drug testing program (SATURN) for high school student athletes
Trial: 9037645
Drug: Protocol group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol group (oxygen delivery targeted towards 600 ml/min/m2)
Trial: 8198908
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion for induction and maintenance (target concentration 8 micrograms ml-1)
Trial: 8198908
Drug: Propofol bolus
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol bolus (2.5-3.5 mg kg-1)
Trial: 8198908
Drug: Thiopentone (4-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone (4-5 mg kg-1)
Trial: 12686786
Drug: Nimodipine treatment
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nimodipine treatment
Trial: 30488350
Drug: Gemcitabine (G)
DrugBank: Gemcitabine (DB00441)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Gemcitabine (G) 800 mg/m2 bi-weekly and Temsirolimus (T) 10 mg weekly, escalated until dose-limiting toxicities (DLTs) were reached.
Trial: 30488350
Drug: Gemcitabine (G)
DrugBank: Gemcitabine (DB00441)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Gemcitabine (G) and Temsirolimus (T) combination treatment.
Trial: 26104022
Drug: Triple plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple plus bismuth therapy
Trial: 24124451
Drug: OPAL-HIV-Gag(c) 12
RxNorm normalized name: carbetapentane tannate / chlorpheniramine tannate Oral Suspension [C-Tanna 12]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPAL-HIV-Gag(c) 12 mg
Trial: 24124451
Drug: OPAL-HIV-Gag(c) 24
RxNorm normalized name: C.i. solvent red 24
DrugBank: Scarlet red (DB19136)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPAL-HIV-Gag(c) 24 mg
Trial: 21918162
Drug: Nebulization of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulization of ropivacaine 1%, 3 mL before and after surgery
Trial: 21918162
Drug: Instillation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instillation of ropivacaine 0.5%, 20 mL after induction of the pneumoperitoneum
Trial: 15269135
Drug: Aromasin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aromasin (25 mg daily)
Trial: 15269135
Drug: Femara (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Femara (2.5 mg daily)
Trial: 11359133
Drug: 1 mL
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mL fibrin glue with 4% lidocaine chloride (group C)
Trial: 11359133
Drug: 1 mL
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mL fibrin glue using CaCl2 as solution to dissolve thrombin (group B)
Trial: 9694028
Drug: D-fenfluramine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-fenfluramine (30 mg)
Trial: 8481358
Drug: Neoadjuvant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant treatment with medroxyprogesterone acetate (MPA) 100 mg t.i.d. p.o. from diagnosis for 90 days
Trial: 2906343
Drug: Triphasic oral
RxNorm normalized name: CeeNU, triphasic oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel (LNG)
Trial: 2906343
Drug: Triphasic oral
RxNorm normalized name: CeeNU, triphasic oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triphasic oral contraceptive containing ethinyl estradiol and gestodene (GTD)
Trial: 16238558
Drug: Ring Block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ring Block (RB) with 1-1.5 ml
Trial: 16238558
Drug: Dorsal Penile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorsal Penile Block with 1.5-4 ml
Trial: 16238558
Drug: Combined Ring
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined Ring and Dorsal Penile Block with 2.5-5 ml
Trial: 11991432
Drug: Contraceptive steroid
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive steroid treatment followed by estrogen replacement therapy
Trial: 11991432
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of estrogens and a progestin
Trial: 11991432
Drug: No estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No estrogen replacement therapy
Trial: 7596116
Drug: Losartan potassium
RxNorm normalized name: Losartan Potassium
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan potassium (100 mg)
Trial: 7596116
Drug: Losartan potassium
RxNorm normalized name: Losartan Potassium
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan potassium (100 mg) after salt depletion
Trial: 2193713
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg flunarizine
Trial: 2193713
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg flunarizine
Trial: 23140261
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg single dose)
Trial: 21856480
Drug: Omecamtiv mecarbil
RxNorm normalized name: omecamtiv mecarbil
DrugBank: Omecamtiv Mecarbil (DB11816)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omecamtiv mecarbil (0.5 mg/kg per h)
Trial: 21856480
Drug: Omecamtiv mecarbil
RxNorm normalized name: omecamtiv mecarbil
DrugBank: Omecamtiv Mecarbil (DB11816)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omecamtiv mecarbil (various doses from 0.005 to 1.0 mg/kg per h)
Trial: 19247541
Drug: Mitt use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitt use during therapy
Trial: 19247541
Drug: No mitt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No mitt use during therapy
Trial: 31888723
Drug: Metoprolol (95
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (95 mg daily for 6 months)
Trial: 26378681
Drug: Salsalate (2500-4500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salsalate (2500-4500 mg for 4 days)
Trial: 23694720
Drug: LY2140023 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2140023 (40 mg BID)
Trial: 9415330
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (diphenhydramine, Maalox, and local analgesic)
Trial: 31944546
Drug: Higher starting
RxNorm normalized name: venetoclax
DrugBank: Venetoclax (DB11581)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Higher starting dose of insulin glargine 100 U/mL (0.3 U/kg)
Trial: 31944546
Drug: Standard starting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard starting dose of insulin glargine 100 U/mL (0.2 U/kg)
Trial: 26537735
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (FO) supplementation, 6 g daily (3.9 g n-3 PUFA) for 9 months
Trial: 26537735
Drug: Maize oil
RxNorm normalized name: Maize oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maize oil (MO) supplementation, 6 g daily for 9 months
Trial: 7783313
Drug: TAZ/PIPC (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAZ/PIPC (2.5 g twice a day for 14 days)
Trial: 7783313
Drug: PIPC (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PIPC (2.0 g twice a day for 14 days)
Trial: 2128828
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with leuprolide and flutamide
Trial: 319662
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (5 to 10 mg)
Trial: 319662
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (10 to 30 mg)
Trial: 319662
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (7.5 to 20 mg)
Trial: 31250758
Drug: M2000 (mannuronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M2000 (mannuronic acid) 500mg orally twice per day for 12 weeks
Trial: 28237542
Drug: Single-implant retained
RxNorm normalized name: betaine
DrugBank: Betaine (DB06756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-implant retained overdentures
Trial: 28237542
Drug: Two-implant retained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-implant retained overdentures
Trial: 20495936
Drug: Non-surgical periodontal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-surgical periodontal treatment during gestation
Trial: 9373050
Drug: Isradipine (2.5-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (2.5-5 mg, slow-release)
Trial: 8207317
Drug: LMWH-Fluxum 3200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LMWH-Fluxum 3200 IUaXa daily (Group A)
Trial: 8207317
Drug: Calcium heparin
RxNorm normalized name: HEPARIN CALCIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium heparin 5000 IU three times daily (Group B)
Trial: 26728864
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of alcoholic drinks at least weekly
Trial: 18433425
Drug: yohimbine 16.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: yohimbine 16.2 mg p.o. t.i.d. for 7 days
Trial: 16154274
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine (4-6mg dosed by ideal body weight)
Trial: 16154274
Drug: Morphine minus
RxNorm normalized name: Arctium minus root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine minus placebo analgesia calculation
Trial: 14989112
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of inhaled corticosteroid (ICS) therapy
Trial: 14989112
Drug: Inhaled corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroid (ICS) therapy continued
Trial: 14989112
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of ICS therapy
Trial: 6383927
Drug: Monotard MC
RxNorm normalized name: MC-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotard MC + Actrapid MC (human insulin)
Trial: 6383927
Drug: Monotard HM
RxNorm normalized name: DEXTRAN HM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotard HM + Actrapid HM (porcine insulin)
Trial: 30052317
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of a representative antiperspirant formulation containing 26 Al chlorohydrate (ACH)
Trial: 22941746
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy for UHR patients plus treatment as usual (CBTuhr)
Trial: 19838862
Drug: Crocus sativus
RxNorm normalized name: CROCUS SATIVUS WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crocus sativus (saffron) 30 mg/day (15 mg twice per day)
Trial: 19838862
Drug: Donepezil 10
RxNorm normalized name: donepezil 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 10 mg/day (5 mg twice per day)
Trial: 18023680
Drug: Coronary artery
RxNorm normalized name: Drug-coated coronary artery stent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coronary artery bypass grafting with intensive medical therapy
Trial: 18023680
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy and coronary artery bypass grafting
Trial: 18023680
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy and coronary artery bypass grafting with surgical ventricular reconstruction
Trial: 12045679
Drug: NNRTI-containing triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NNRTI-containing triple therapy
Trial: 12045679
Drug: 5-drug regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-drug regimen
Trial: 12045679
Drug: PI-containing triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PI-containing triple therapy
Trial: 12045679
Drug: Double NRTI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double NRTI therapy
Trial: 9528731
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg once daily for 12 weeks
Trial: 9528731
Drug: Immediate-release niacin
RxNorm normalized name: niacin Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release niacin 1 g three times daily for 12 weeks
Trial: 2104939
Drug: Indomethacin (Indo)
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin (Indo) 100 mg IV 6 hours postoperatively and 3 x 50 mg IV Indo over 24 hours on postoperative days 1, 2, 3, 4
Trial: 27591917
Drug: Defined symptom-change
RxNorm normalized name: Pamprin Multi-Symptom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Defined symptom-change trajectories (linear, log-linear, one-step) during acute-phase cognitive therapy
Trial: 20594395
Drug: 150 g
RxNorm normalized name: TOCOPHEROL 2 g in 150 g TOPICAL OIL [TUREMRIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 g farmed trout raised on marine feed
Trial: 20594395
Drug: 150 g
RxNorm normalized name: TOCOPHEROL 2 g in 150 g TOPICAL OIL [TUREMRIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 g farmed trout raised on vegetable feed
Trial: 20594395
Drug: 150 g
RxNorm normalized name: TOCOPHEROL 2 g in 150 g TOPICAL OIL [TUREMRIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 g chicken
Trial: 17321529
Drug: 400 mug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mug of oral misoprostol
Trial: 17321529
Drug: 5 U
RxNorm normalized name: vitamin E 5 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 U of intravenous oxytocin
Trial: 7737719
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg oral bromocriptine
Trial: 2202544
Drug: Piroxicam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam (20 mg daily)
Trial: 2202544
Drug: Diclofenac (75‐150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (75‐150 mg daily)
Trial: 28635359
Drug: Intravenous patient-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient-controlled analgesia (IVPCA)
Trial: 21093145
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dutasteride (0.5 mg/d) and tamsulosin (0.4 mg/d)
Trial: 21093145
Drug: Tamsulosin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (0.4 mg/d)
Trial: 17252176
Drug: Early rehabilitation
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early rehabilitation by a rehabilitation specialist, including tailored treatment for post-concussion symptoms (PCS).
Trial: 6354604
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (Atenolol 100 mg + Indapamide 2.5 mg)
Trial: 31923300
Drug: Immediate loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate loading of mini-implants with housings and O-rings (insertion torque ≥ 35 Ncm) or soft relining material (insertion torque < 35 Ncm)
Trial: 31923300
Drug: Delayed loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed loading of mini-implants (group B)
Trial: 27885399
Drug: Oral selexipag
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral selexipag (400 μg)
Trial: 27885399
Drug: Intravenous selexipag
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous selexipag (200 μg)
Trial: 26200270
Drug: Folate receptor-positive
RxNorm normalized name: folate
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folate receptor-positive circulating tumor cells (CTCs) detection using ligand-targeted PCR technique
Trial: 22657533
Drug: PZQ syrup
RxNorm normalized name: L-PZQ
DrugBank: (R)-Praziquantel (DB11749)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PZQ syrup
Trial: 22657533
Drug: Crushed PZQ
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed PZQ tablet
Trial: 18822974
Drug: Routine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine therapy for diabetes mellitus with acupuncture at Weiwanxiashu, Feishu, Pishu, Shenshu, Yanglingquan
Trial: 11979157
Drug: Light multidisciplinary
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light multidisciplinary treatment
Trial: 11790467
Drug: Extensive multidisciplinary
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extensive multidisciplinary treatment
Trial: 10606107
Drug: Cilostazol plus
RxNorm normalized name: Cilostazol
DrugBank: Cilostazol (DB01166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cilostazol plus aspirin (C+A)
Trial: 10606107
Drug: Ticlopidine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine plus aspirin (T+A)
Trial: 8941534
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g HMB/day
Trial: 8941534
Drug: 3.0 g
RxNorm normalized name: LACTIC ACID 23.0 g in 1 L TOPICAL SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0 g HMB/day
Trial: 6406458
Drug: bupropion, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupropion, 50 mg
Trial: 6406458
Drug: bupropion, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupropion, 100 mg
Trial: 6406458
Drug: bupropion, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupropion, 200 mg
Trial: 6406458
Drug: bupropion, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupropion, 100 mg with diazepam, 2.5 and 5 mg
Trial: 6406458
Drug: bupropion, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupropion, 100 mg with alcohol
Trial: 6406458
Drug: d‐amphetamine, 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d‐amphetamine, 5 and 10 mg